The Clinical Effectiveness of Denosumab (Prolia®) for the Treatment of Osteoporosis in Postmenopausal Women, Compared to Bisphosphonates, Selective Estrogen Receptor Modulators (SERM), and Placebo: A Systematic Review and Network Meta-Analysis Magdalena Ruth MoshiKonstance NicolopoulosThomas Vreugdenburg Review Article 05 April 2023 Pages: 631 - 646
Spondyloarthritis and Sarcopenia: Prevalence of Probable Sarcopenia and its Impact on Disease Burden: The Saspar Study Blandine MerleMarie CottardRoland Chapurlat Original Research 21 March 2023 Pages: 647 - 655
Advancing Use of DEXA Scans to Quantitatively and Qualitatively Evaluate Lateral Spinal Curves, for Preliminary Identification of Adolescent Idiopathic Scoliosis P. T. T. NgL. StrakerA. Claus Original Research Open access 13 March 2023 Pages: 656 - 665
Hip Labral Morphological Changes in Patients with Femoroacetabular Impingement Speed Up the Onset of Early Osteoarthritis Michela BattistelliEnrico TassinariEleonora Olivotto Original Research Open access 22 March 2023 Pages: 666 - 674
Bone Tissue Evaluation Indicates Abnormal Mineralization in Patients with Autoimmune Polyendocrine Syndrome Type I: Report on Three Cases Saila LaaksoTong XiaoyuMarkus A. Hartmann Original Research Open access 22 March 2023 Pages: 675 - 682
Comparison of the Efficacy of Zoledronate Acid or Denosumab After Switching from Romosozumab in Japanese Postmenopausal Patients Tetsuro OueTomohiro ShimizuNorimasa Iwasaki Original Research 10 April 2023 Pages: 683 - 690
Radial HR-pQCT and Finite Element Analysis in HPP Patients are Superior in Identifying Susceptibility to Fracture-Associated Skeletal Affections Compared to DXA and Laboratory Tests Felix N. SchmidtConstantin SchmidtFlorian Barvencik Original Research Open access 06 May 2023 Pages: 691 - 703
Oridonin Attenuates Thioacetamide-Induced Osteoclastogenesis Through MAPK/NF-κB Pathway and Thioacetamide-Inhibited Osteoblastogenesis Through BMP-2/RUNX2 Pathway XiaoLi JinJia XuJian Xu Original Research Open access 09 April 2023 Pages: 704 - 715
Non-psychoactive Cannabidiol Prevents Osteoporosis in an Animal Model and Increases Cell Viability, Proliferation, and Osteogenic Gene Expression in Human Skeletal Stem and Progenitor Cells Rivka Ihejirika-LomedicoKaran PatelPhilipp Leucht Original Research 24 April 2023 Pages: 716 - 726
